USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
The Development of Novel Radiopharmaceuticals and the Expanding Clinical Applications for Molecular Imaging Equipment will Create Opportunities for the Growth of Procedures
22-Feb-2022
North America
Market Research
PCB3-01-00-00-00
HC03510-NA-MT_26299
This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure volumes in the United States and EU-5 countries, including Germany, France, Italy, the United Kingdom, and Spain.
More than 36 million MI procedures are carried out, globally, and this number is increasing by 4%–6%, annually, driven by the rising number of patients with cancer, cardiac disease, and neurological ailments. Owing to the surging MI procedures, demand for the in-house production of radioisotopes using cyclotrons is rising. In addition, due to technology advancements and investments in R&D, new radiotracers have been developed, which has expanded the clinical application of MI equipment in neurology and oncology.
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Molecular Imaging (MI) Procedures Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Market Segmentation
Therapeutic Indications
Molecular Imaging Procedures Ecosystem—Present and Future
Key Highlights
Key Growth Metrics
Procedures Forecast
Procedures Forecast by Product Segment
COVID-19 Impact and Challenges Outlook, 2022
PET/CT Procedures by Clinical Application
Procedure Volume by Clinical Application
Procedure Volume by Geography
Key Trends—The Introduction of New Radiopharmaceuticals will Accelerate the Growth of PET/CT Imaging Procedures
Key Trends—The Next Big Opportunity for PET Scanning Lies in its Potential to Aid the Diagnosis of Alzheimer’s Disease
SPECT/CT Procedures by Clinical Application
Procedure Volume by Clinical Application
Procedure Volume by Geography
Technology is Set to Take Center Stage
Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers
Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers (continued)
Hospital Landscape and MI Equipment Infrastructure—United States
Hospital Landscape and MI Equipment Infrastructure—Germany
Hospital Landscape and MI Equipment Infrastructure—France
Hospital Landscape and MI Equipment Infrastructure—Italy
Hospital Landscape and MI Equipment Infrastructure—Spain
Hospital Landscape and MI Equipment Infrastructure—United Kingdom
Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides
Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides (continued)
Growth Opportunity 2—AI Platforms in MI for Improved Patient Care
Growth Opportunity 2—AI Platforms in MI for Improved Patient Care (continued)
Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology
Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology (continued)
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Molecular Imaging Procedures: Key Growth Metrics, Global, 2021
- Molecular Imaging Procedures: Procedures Forecast, Global, 2019–2026
- Molecular Imaging Procedures: Procedures Forecast by Product Segment, Global, 2019–2026
- Molecular Imaging Procedures: PET/CT Procedure Volume Percent by Clinical Application, Global, 2021
- Molecular Imaging Procedures: PET/CT Procedure Volume Percent Forecast by Clinical Application, Global, 2026
- Molecular Imaging Procedures: PET/CT Procedure Volume by Clinical Application, Global, 2019–2026
- Molecular Imaging Procedures: Procedure Volume by Geography, Global, 2019–2026
- Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent by Clinical Application, North America, 2021
- Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent Forecast by Clinical Application, North America, 2026
- Molecular Imaging Procedures: SPECT/CT Procedure Volume by Clinical Application, Global, 2019–2026
- Molecular Imaging Procedures: SPECT/CT Estimated procedures by Geography, Global, 2019–2026
- Molecular Imaging Procedures: Installed Cyclotron Base, Global, 2020
- Molecular Imaging Procedures: Cyclotron Installed Base by Manufacturer, Global, 2020
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, the United States, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Germany, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, France, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Italy, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, Spain, 2021
- Molecular Imaging Procedures: Procedure Volumes by Care Settings, UK, 2021
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| List of Charts and Figures | Molecular Imaging Procedures: Key Growth Metrics, Global, 2021~ Molecular Imaging Procedures: Procedures Forecast, Global, 2019–2026~ Molecular Imaging Procedures: Procedures Forecast by Product Segment, Global, 2019–2026~ Molecular Imaging Procedures: PET/CT Procedure Volume Percent by Clinical Application, Global, 2021~ Molecular Imaging Procedures: PET/CT Procedure Volume Percent Forecast by Clinical Application, Global, 2026~ Molecular Imaging Procedures: PET/CT Procedure Volume by Clinical Application, Global, 2019–2026~ Molecular Imaging Procedures: Procedure Volume by Geography, Global, 2019–2026~ Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent by Clinical Application, North America, 2021~ Molecular Imaging Procedures: SPECT/CT Procedure Volume Percent Forecast by Clinical Application, North America, 2026~ Molecular Imaging Procedures: SPECT/CT Procedure Volume by Clinical Application, Global, 2019–2026~ Molecular Imaging Procedures: SPECT/CT Estimated procedures by Geography, Global, 2019–2026~ Molecular Imaging Procedures: Installed Cyclotron Base, Global, 2020~ Molecular Imaging Procedures: Cyclotron Installed Base by Manufacturer, Global, 2020~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, the United States, 2021~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, Germany, 2021~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, France, 2021~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, Italy, 2021~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, Spain, 2021~ Molecular Imaging Procedures: Procedure Volumes by Care Settings, UK, 2021~ |
| Author | Vishnu Bhargav Yanamandra |
| Industries | Healthcare |
| WIP Number | PCB3-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9825-B1,9A06-B1,9566-B1,9570-B1,99CC-B1,99BE-B1,9614-B1 |
Global Molecular Imaging Procedures Growth Opportunities
$2,450.00
Special Price $1,837.50 save 25 %